Attilio Maseri

Clinical Cardiology
C Richard Conti

Abstract

Professor Attilio Maseri is a clinical investigator with a remarkable track record of innovative research who, by changing traditional paradigms, contributed to shape new diagnostic techniques in pathophysiologic thinking. His research has been characterized by challenging the generalizations of accepted "wisdom" which did not offer satisfactory explanations for the observations he made in his clinical practice. The results of his clinical investigations have contributed greatly to the opening of new avenues of research and patient management in the field of ischemic heart disease. His clinical and research experiences are catalogued in 740 pages of his single-authored textbook Ischemic Heart Disease. A Rational Basis for Clinical Practice and Clinical Research. This book chronicles Maseri's novel unifying vision of ischemic heart disease. In 2001, Professor Maseri left Catholic University in Rome to take on bigger challenges in Milan where he is now functioning as Professor of Cardiology at the University Vita-Salute San Raffaele and Director of the Cardio-Thoracic and Vascular Department of the San Raffaele Scientific Institute. His research interests include application of molecular biology, differential gene expression prof...Continue Reading

Citations

Sep 1, 1987·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·J S Moshides

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.